Wheat Germ Extract Shows Potent Anti-Cancer Activity

Dear Friend,

For years, doctors have been advising that a nutritious diet low in fat and rich in antioxidants is beneficial in preventing cancer and helpful in boosting the health of cancer patients. Studies show that fermented wheat germ extract (FWGE), a popular staple in health food stores, can be a potent anti-cancer dietary supplement.

What Is Fermented Wheat Germ Extract?

Quite simply, wheat germ is extracted from the germ, or seed, of a wheat plant. FWGE is wheat germ fermented with baker's yeast to create a concentration of an active substance called benzoquinones.

FWGE is sold under the trade name of Avemar in Hungary, where it's registered as a special nutriment for cancer patients. (Avemar is marketed as AWGE in the U.S.) In the 1990s, the fermentation process was patented by a group of Hungarian scientists who also conducted in vitro and human clinical trials.

Anti-Cancer Properties of Avemar

Cancer cells use glucose as building blocks for rapid proliferation. As the tumor grows, it continues consuming more and more of the available glucose, causing the cancer patient to experience fatigue and weight loss.

In addition to interfering with a tumor's glucose metabolism, Avemar has applications for immunotherapy for cancer as an NK cell activator. Both processes result in apoptosis, or "suicide" of cancer cells.

Immunotherapy for Cancer: A Non-Toxic, Integrative Approach

At Issels®, we evaluate your individual case along with factors such as lifestyle and environment to create a personalized course of treatment. Visit our website to learn more about innovative methods such as cancer vaccines and gene-targeted therapies.

Read more interesting articles on the "Issels Cancer Immunotherapy" news/blog posted every Tuesday and Thursday. Check It Out Now »

Off Label Drug Use Rises In Fight against Cancer

While testing current drugs, the team discovered that axitinib, a drug used on kidney cancer, has properties that knock out communication paths between mutant cells. Since 90 percent of all cancers are caused by mutations, researchers are hopeful that the drug can be used for breast, prostate, colorectal and other forms of cancer.
With the development of new pharmaceuticals taking up to 10 years, repurposing has become a popular cost- and time-effective strategy.

Dendritic cells act as coordinators between the innate immune system, which provides the initial response to pathogens, and the adaptive immune system, which offers a long-lasting defense against the invading cells. When foreign organisms are detected, dendritic cells capture their markers, or antigens, for presentation to T-lymphocyte cells, triggering the attack on the pathogens.